nadp has been researched along with Myeloproliferative Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaiswal, AK; Xu, J | 1 |
| Gaikwad, A; Gonzalez, FJ; Jaiswal, AK; Long, DJ; Montgomery, CA; Multani, A; Pathak, S | 1 |
| Okuma, M; Sugiyama, T; Uchino, H | 1 |
3 other study(ies) available for nadp and Myeloproliferative Disorders
| Article | Year |
|---|---|
NAD(P)H:quinone oxidoreductase 1 (NQO1) competes with 20S proteasome for binding with C/EBPα leading to its stabilization and protection against radiation-induced myeloproliferative disease.
Topics: Amino Acid Substitution; Animals; Bone Marrow; CCAAT-Enhancer-Binding Proteins; Gamma Rays; HL-60 Cells; Humans; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Mutation, Missense; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); NADP; Proteasome Endopeptidase Complex; Protein Binding; Protein Stability; Proteolysis; Radiation Injuries, Experimental | 2012 |
Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia.
Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Differentiation; Chromosomes; DNA-Binding Proteins; Female; Genes, Tumor Suppressor; Hyperplasia; Male; Mice; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); NADP; Nuclear Proteins; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2002 |
Platelet prostaglandin D2 dehydrogenase in patients with myeloproliferative disorders.
Topics: Adult; Age Factors; Aged; Blood Platelets; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Male; Middle Aged; Myeloproliferative Disorders; NADP; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Sex Factors | 1986 |